These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33101778)

  • 1. Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosis.
    Nugteren S; Goos JACM; Delis-van Diemen PM; Simons-Oosterhuis Y; Lindenbergh-Kortleve DJ; van Haaften DH; Sanders J; Meijer GA; Fijneman RJA; Samsom JN
    Oncoimmunology; 2020 Oct; 9(1):1832761. PubMed ID: 33101778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of secretory leukocyte protease inhibitor (SLPI) in stage III micro-satellite stable colorectal cancer is associated with reduced disease recurrence.
    Nugteren S; den Uil SH; Delis-van Diemen PM; Simons-Oosterhuis Y; Lindenbergh-Kortleve DJ; van Haaften DH; Stockmann HBAC; Sanders J; Meijer GA; Fijneman RJA; Samsom JN
    Sci Rep; 2022 Jul; 12(1):12174. PubMed ID: 35842496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretory leukocyte protease inhibitor (SLPI) in cancer pathophysiology: Mechanisms of action and clinical implications.
    Zhang X; Liu SS; Ma J; Qu W
    Pathol Res Pract; 2023 Aug; 248():154633. PubMed ID: 37356220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1.
    Påhlman LI; Jögi A; Gram M; Mori M; Egesten A
    BMC Pulm Med; 2015 Mar; 15():19. PubMed ID: 25851169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretory Leukocyte Protease Inhibitor (SLPI) in mucosal tissues: Protects against inflammation, but promotes cancer.
    Nugteren S; Samsom JN
    Cytokine Growth Factor Rev; 2021 Jun; 59():22-35. PubMed ID: 33602652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of secretory leukocyte protease inhibitor detected by immunohistochemistry correlating with prognosis and metastasis in colorectal cancer.
    Liu G; Yang J; Zhao Y; Wang Z; Xing B; Wang L; Shi D
    World J Surg Oncol; 2014 Dec; 12():369. PubMed ID: 25441765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretory leukocyte protease inhibitor inhibits expression of polymeric immunoglobulin receptor via the NF-κB signaling pathway.
    Mikami Y; Iwase T; Komiyama Y; Matsumoto N; Oki H; Komiyama K
    Mol Immunol; 2015 Oct; 67(2 Pt B):568-74. PubMed ID: 26239418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human buccal epithelium acquires microbial hyporesponsiveness at birth, a role for secretory leukocyte protease inhibitor.
    Menckeberg CL; Hol J; Simons-Oosterhuis Y; Raatgeep HR; de Ruiter LF; Lindenbergh-Kortleve DJ; Korteland-van Male AM; El Aidy S; van Lierop PP; Kleerebezem M; Groeneweg M; Kraal G; Elink-Schuurman BE; de Jongste JC; Nieuwenhuis EE; Samsom JN
    Gut; 2015 Jun; 64(6):884-93. PubMed ID: 25056659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease inhibitory activity of secretory leukocyte protease inhibitor ameliorates murine experimental colitis by protecting the intestinal epithelial barrier.
    Ozaka S; Sonoda A; Ariki S; Kamiyama N; Hidano S; Sachi N; Ito K; Kudo Y; Minata M; Saechue B; Dewayani A; Chalalai T; Soga Y; Takahashi Y; Fukuda C; Mizukami K; Okumura R; Kayama H; Murakami K; Takeda K; Kobayashi T
    Genes Cells; 2021 Oct; 26(10):807-822. PubMed ID: 34379860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous secretory leukocyte protease inhibitor inhibits microbial-induced monocyte activation.
    Nugteren S; Simons-Oosterhuis Y; Menckeberg CL; Hulleman-van Haaften DH; Lindenbergh-Kortleve DJ; Samsom JN
    Eur J Immunol; 2023 Feb; 53(2):e2249964. PubMed ID: 36480463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of secretory leukocyte protease inhibitor (SLPI) promotes the PUMA-mediated apoptosis and chemosensitivity to cisplatin in colorectal cancer cells.
    Wei Z; Liu G; Jia R; Zhang W; Li L; Zhang Y; Wang Z; Bai X
    Discov Oncol; 2023 Jan; 14(1):1. PubMed ID: 36595102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nodal metastasis and survival in oral cancer: Association with protein expression of SLPI, not with LCN2, TACSTD2, or THBS2.
    Noorlag R; van der Groep P; Leusink FK; van Hooff SR; Frank MH; Willems SM; van Es RJ
    Head Neck; 2015 Aug; 37(8):1130-6. PubMed ID: 24764155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretory leukocyte protease inhibitor regulates human periodontal ligament cell production of pro-inflammatory cytokines.
    Svensson D; Aidoukovitch A; Anders E; Jönsson D; Nebel D; Nilsson BO
    Inflamm Res; 2017 Sep; 66(9):823-831. PubMed ID: 28597116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression and clinical significance of secretory leukocyte proteinase inhibitor (SLPI) in mammary carcinoma using bioinformatics analysis.
    Xie W; Zhang H; Qin S; Zhang J; Fan X; Yin Y; Liang R; Long H; Yi W; Fu D; Ma C; Lv M; Yu F
    Gene; 2019 Dec; 720():144088. PubMed ID: 31476404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus infection in head and neck cancer: the role of the secretory leukocyte protease inhibitor.
    Hoffmann M; Quabius ES; Tribius S; Hebebrand L; Görögh T; Halec G; Kahn T; Hedderich J; Röcken C; Haag J; Waterboer T; Schmitt M; Giuliano AR; Kast WM
    Oncol Rep; 2013 May; 29(5):1962-8. PubMed ID: 23467841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The secretory leukocyte protease inhibitor (SLPI) suppresses cancer cell invasion but promotes blood-borne metastasis via an invasion-independent pathway.
    Sugino T; Yamaguchi T; Ogura G; Kusakabe T; Goodison S; Homma Y; Suzuki T
    J Pathol; 2007 Jun; 212(2):152-60. PubMed ID: 17455170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretory leukocyte protease inhibitor is a survival and proliferation factor for castration-resistant prostate cancer.
    Zheng D; Gui B; Gray KP; Tinay I; Rafiei S; Huang Q; Sweeney CJ; Kibel AS; Jia L
    Oncogene; 2016 Sep; 35(36):4807-15. PubMed ID: 26876202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.
    Xu CB; Liu XS; Li JQ; Zhao X; Xin D; Yu D
    J Cell Biochem; 2019 Jun; 120(6):10830-10846. PubMed ID: 30706537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of protease inhibitor-dead secretory leukocyte protease inhibitor causes more aggressive ovarian cancer in vitro and in vivo.
    Devoogdt N; Rasool N; Hoskins E; Simpkins F; Tchabo N; Kohn EC
    Cancer Sci; 2009 Mar; 100(3):434-40. PubMed ID: 19154415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive and regulated secretion of secretory leukocyte proteinase inhibitor by human intestinal epithelial cells.
    Si-Tahar M; Merlin D; Sitaraman S; Madara JL
    Gastroenterology; 2000 Jun; 118(6):1061-71. PubMed ID: 10833481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.